nonalcoholic steatohepatitis
Conditions
Interventions
None listed
Sponsors
Takeuchi Yutaka
EA Pharma Co., Ltd
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Subjects who received multiple doses of placebo-or EA3571 in a Phase 1 study of EA3571 in healthy adult subjects
Exclusion criteria
Exclusion criteria: Subjects who refused to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma hormone concentration | — |
Contacts
Public ContactYutaka Takeuchi
EA Pharma Co., Ltd
Outcome results
None listed